Financial Gravity Companies’s Amneal Pharmaceuticals AMRX Stock Holding History

Financial Gravity Companies’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$1K	Buy	+76	New	+$1.37K	﹤0.01%	1012

Other funds holding AMRX

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Financial Gravity Companies's AMRX Position: Q4 2018 in Review

Financial Gravity Companies opened a new position in Amneal Pharmaceuticals (AMRX) in Q4 2018: 76 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #1012 among its holdings.

168 funds tracked by Wall St. Rank hold AMRX as of Q4 2018.

Financial Gravity Companies held 76 shares of Amneal Pharmaceuticals worth $1K as of Q4 2018.
Amneal Pharmaceuticals was a new Financial Gravity Companies position in Q4 2018.
Amneal Pharmaceuticals made up ﹤0.01% of Financial Gravity Companies's portfolio in Q4 2018, its #1012 holding.
168 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q4 2018.

Based on Financial Gravity Companies's 13F filing for Q4 2018, filed 4 Feb 2019.